Limitation of Infarct Size in Rabbit Hearts by the Novel Adenosine Receptor Agonist AMP 579 Administered at Reperfusion

This publication has 19 references indexed in Scilit:

• Failure of N-2-mercaptopropionyl glycine to reduce myocardial infarction after 3 days of reperfusion in rabbits.
  Basic Research in Cardiology, 1999
• Cardiovascular Pharmacology of the Adenosine A1/A2-Receptor Agonist AMP 579: Coronary Hemodynamic and Cardioprotective Effects in the Canine Myocardium
  Journal of Cardiovascular Pharmacology, 1999
• Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes
  Coronary Artery Disease, 1999
• Fostriecin, an Inhibitor of Protein Phosphatase 2A, Limits Myocardial Infarct Size Even When Administered After Onset of Ischemia
  Circulation, 1998
• Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs
  Cardiovascular Research, 1996
• Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia.
  Circulation, 1992
• Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.
  Circulation, 1992
• Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.
  Circulation, 1991
• Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart
  Journal of Molecular and Cellular Cardiology, 1989
• Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.
  Circulation, 1987